Skip to content
Doctor talking to a patient

Expand Treatment Options for Men With BPH

Primary care physicians have previously had limited options for patients with BPH. The choices typically involved prescribing medications or referring patients for invasive surgery. The UroLift™ System provides a proven alternative. It is the number one minimally invasive BPH procedure chosen by urologists and their patients in the U.S.,1 and it has been performed on over 450,000 patients worldwide.2

Find a UroLift System-Trained Physician

Are you frustrated by medication nonadherence and the challenges of polypharmacy?

50
%

Of men surveyed are dissatisfied with the effectiveness of their BPH medication.3

71
%

Of patients are non-adherent with their BPH medications after one year.4

48
%

Of men on BPH medications experience <4 point IPSS symptom improvement5

Help Your Patients Preserve Bladder Health

Impact on wellbeing
Quality of life and overall health are important considerations in treating men with BPH. Watchful waiting can risk long-term bladder health.6 The use of BPH medications may be associated with potential side effects,7 and many men are dissatisfied with the effectiveness of their BPH medication in relieving symptoms.3,5

Help your patients take a proactive role in their BPH care by introducing them to BPH Advisor™, a free personalized education program.

Bladder Disease Progression from a healthy bladder to a permanently damaged bladder

“Since many men discontinue medical therapy, yet proportionately few seek surgery, there is a large clinical need for an effective treatment that is less invasive than surgery.”

American Urological Association BPH Guidelines 2021

Common Questions Your Patients May Ask

Icon of a magnifying glass

What’s the harm in watchful waiting?

87% of men who elect watchful waiting reported a worsening of symptoms over a 4-year period.9

Icon of a pill with a cancel symbol

Can I continue taking my BPH medications forever? 

Some BPH medications have been associated with serious issues, such as increased risk of cardiac failure and impaired cognitive function.10,11

Icon of two people in bed

What about sexual function?

UroLift™ System patients reported better outcomes in sexual function* and satisfaction than men who received BPH medication.12

How the UroLift™ System Is Unique

A mechanical solution to a mechanical problem

The UroLift™ System uses a proven approach to treating BPH that lifts and holds the enlarged prostate tissue out of the way, so it no longer blocks the urethra.15 It is the only leading transurethral BPH treatment that does not require heating, cutting or removal of the prostate tissue.13,14 Post-procedure, most patients do not require ongoing BPH medications.15

Refer your appropriate patients to a urologist who can determine if they are a candidate for the UroLift™ System.

The UroLift™ System reopens the channel—with no cutting or burning of the prostate.

Silhouette of a person with a speech bubble

Connect with a Teleflex representative to learn more and get resources for your staff and patients.

Icon of a checklist

Download an IPSS form to help identify patients who may benefit from the UroLift™ System treatment.

Man holding a pill bottle while talking to a doctor
“It is our responsibility to educate the patient about all the options. Many of my patients prefer the UroLift™ System procedure over a pill.”
Dr. Robert Cowles+
“I’m extremely satisfied and eternally grateful for the great outcome. It was absolutely worth it. I’d do it again in a heartbeat.”
Steve K, 63
Steve K., "Mr. Gadget" wanted to stop taking BPH medications.
Read Steve's Story

References

  • 1. U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22 FINAL), which is in part based on Symphony Health PatientSource® 2018-21, as is and with no representations/warranties, including accuracy or completeness.

  • 2. Management estimate based on product sales as of September 2023. Data on file Teleflex Interventional Urology.

  • 3. Survey of US men aged 40+ who have been diagnosed with BPH (enlarged prostate) and are/have been treated with BPH medications, conducted by Teleflex in 2020. Data on file, n=96.

  • 4. Cindolo, Eur Urol 2015

  • 5. Wei, et al, 2010 Abstract

  • 6. Flanigan, J Urol 1998

  • 7. AUA Guidelines 2003

  • 8. Tubaro, Drugs Aging 2003

  • 9. Djavan, Urology 2004

  • 10. Lusty, J Urol 2021

  • 11. Bortnick, Rev Urol 2019

  • 12. Roehrborn, Eur Urol Focus 2021

  • 13. Roehrborn, J Urol 2013

  • 14. AUA Guidelines 2003, 2020

  • 15. Roehrborn, Can J Urol 2017

  • *Based on an indirect comparison of erectile and ejaculatory function and sexual satisfaction in men who received PUL in controlled studies or in men who received medical therapy in the MTOPS study.

  • + Dr. Robert Cowles was previously a paid consultant of Teleflex

MAC12001-03 Rev A